CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 4 Grant or award Director acquired 7,784 shares (grant or award)
- 4 Grant or award Director acquired 8,102 shares (grant or award)
- 4 Grant or award Director acquired 10,168 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CFO and Secretary bought 3,000 shares at $2.43 ($7,290)
- 4 Open-market buy Director bought 7,840 shares at $2.56 ($20,039)
- 4 Open-market buy Chief Medical Officer bought 7,260 shares at $2.67 ($19,365)
- 4 Open-market buy President and CEO bought 1,000 shares at $2.68 ($2,677)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 19,000 shares at $2.80 ($53,200)
- 4 Open-market buy CFO and Secretary bought 4,000 shares at $2.94 ($11,770)
- 4 Open-market buy Chief Medical Officer bought 150 shares at $4.46 ($668)
Page 8 of 9 · 176 filings